(Q38788907)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26943884%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

New Approach for Treatment of Primary Liver Tumors: The Role of Quercetin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26943884%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author

Ana Margarida Abrantes

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26943884%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Mafalda Laranjo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26943884%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Ana Cristina Gonçalves

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26943884%20AND%20SRC:MED&resulttype=core&format=json

Ana Bela Sarmento Ribeiro

9 March 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26943884%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Maria Filomena Botelho

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26943884%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1

Ana Filipa Brito

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26943884%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

José Guilherme Tralhão

9

object named as

José Guilherme Tralhão

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26943884%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

4

Ana Catarina Mamede

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26943884%20AND%20SRC:MED&resulttype=core&format=json

João Eduardo Casalta-Lopes

9 March 2020

6

object named as

João Eduardo Casalta-Lopes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26943884%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Marina Ribeiro

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26943884%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

publication date

1 February 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26943884%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26943884%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26943884%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26943884%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

250-266

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26943884%20AND%20SRC:MED&resulttype=core&format=json

Environmental factors and risk for hepatocellular carcinoma

9 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Hepatocellular carcinoma: A global view.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Hepatocellular carcinoma--epidemiological trends and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Positron emission tomography diagnostic imaging in multidrug-resistant hepatocellular carcinoma: focus on 2-deoxy-2-(18F)Fluoro-D-Glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Targeted therapies for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Systemic therapies in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Focus on hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Systemic chemotherapy of liver tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Approach to radiation therapy in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Hepatocellular carcinoma and chemotherapy: the role of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Diagnosis and treatment of cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

GLUT1 as a therapeutic target in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

The inhibitory effects of flavonoids and antiestrogens on the Glut1 glucose transporter in human erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Quercetin: a potential drug to reverse multidrug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

The flavonoid quercetin in disease prevention and therapy: facts and fancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-κB inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Exploiting tyrosinase expression and activity in melanocytic tumors: quercetin and the central role of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Quercetin potentiates doxorubicin mediated antitumor effects against liver cancer through p53/Bcl-xl

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Quercetin enhances the antitumor activity of trichostatin A through upregulation of p53 protein expression in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Fluorine-18 Fluorodeoxyglucose Uptake in Hepatocellular Carcinoma: Correlation with Glucose Transporters and p53 Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Alterations in the tumor suppressor genes p53, RB, p16/MTS1, and p15/MTS2 in human pancreatic cancer and hepatoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Screening the p53 status of human cell lines using a yeast functional assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Effect of amniotic membrane proteins in human cancer cell lines: an exploratory study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Cytotoxicity of ascorbic acid in a human colorectal adenocarcinoma cell line (WiDr): in vitro and in vivo studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Targeting triple-negative breast cancer cells with 6,7-bis(hydroxymethyl)-1H,3H-pyrrolo[1,2-c]thiazoles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Hypoxia-induced redox alterations and their correlation with 99mTc-MIBI and 99mTc-HL-91 uptake in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Preventive effect of the flavonoid, quercetin, on hepatic cancer in rats via oxidant/antioxidant activity: molecular and histological evidences

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Quercetin induces oxidative stress and potentiates the apoptotic action of 2-methoxyestradiol in human hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Synergetic anticancer effect of combined quercetin and recombinant adenoviral vector expressing human wild-type p53, GM-CSF and B7-1 genes on hepatocellular carcinoma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

The flavonoid quercetin inhibits pancreatic cancer growth in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Effects of quercetin and sunphenon on responses of cancer cells to heat shock damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Apoptosis induction in human glioblastoma multiforme T98G cells upon temozolomide and quercetin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

p73, a sophisticated p53 family member in the cancer world

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

DNA damage-induced cell death by apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Quercetin-induced apoptosis acts through mitochondrial- and caspase-3-dependent pathways in human breast cancer MDA-MB-231 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Reappraisal of the anticancer efficacy of quercetin in oral cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Resveratrol and quercetin-induced apoptosis of human 232B4 chronic lymphocytic leukemia cells by activation of caspase-3 and cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Direct inhibition of the hexose transporter GLUT1 by tyrosine kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Do hyperglycemia and diabetes affect the incidence of false-negative 18F-FDG PET/CT studies in patients evaluated for infection or inflammation and cancer? A Comparative analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Assessment of factors influencing FDG uptake in non-small cell lung cancer on PET/CT by investigating histological differences in expression of glucose transporters 1 and 3 and tumour size

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Sorafenib alone or as combination therapy for growth control of cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenib

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2016.1145245

10.1080/01635581.2016.1145245

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26943884%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference